At a glance
- Originator Dainippon Sumitomo Pharma; Ishihara Sangyo Kaisha
- Class Anti-inflammatories; Pyridines; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatitis